Document Detail


Nephrogenic systemic fibrosis after exposure to gadolinium in patients with renal failure.
MedLine Citation:
PMID:  17890246     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Nephrogenic systemic fibrosis is a debilitating disease occurring exclusively in patients with renal failure. The aetiology of nephrogenic systemic fibrosis is unclear, but recent reports suggest that exposure to gadolinium for enhancement of magnetic resonance imaging may play a role. In the present study, we assessed the association of exposure to gadolinium with the development of nephrogenic systemic fibrosis in patients with various stages of chronic kidney disease. METHODS: We analysed the exposure to gadolinium and development of nephrogenic systemic fibrosis in 849 patients on renal replacement therapy over 5 years. We also performed inquiry of development of the nephrogenic systemic fibrosis in 592 patients exposed to gadolinium and estimated to be in stages 3 and 4 of chronic kidney disease. RESULTS: In 849 patients undergoing chronic dialysis from 2001 through 2006 time period, four of the 261 who had received gadolinium (1.5%) and none of the 588 not exposed to gadolinium developed clinically apparent disease. The odds ratio for developing nephrogenic systemic fibrosis was 6.671 [95% confidence interval (CI) 1.537-53.97] in patients with a single gadolinium exposure compared to patients without gadolinium exposure. This ratio increased to 44.5 (95% CI 2.362-2913) in patients with multiple gadolinium exposures compared to patients not receiving gadolinium. None of the 592 patients estimated to be in stage 3 or 4 of chronic kidney disease developed nephrogenic systemic fibrosis after exposure to gadolinium. CONCLUSION: Gadolinium exposure is associated with nephrogenic systemic fibrosis in patients on chronic renal replacement therapy at a low rate. This association appears to increase with repeated exposure to gadolinium. Since nephrogenic systemic fibrosis may be clinically occult, its prevalence may be higher than reported. Despite this association, it is unclear if gadolinium is the sole or most important factor in the pathogenesis of the disease.
Authors:
Jennifer B Othersen; John C Maize; Robert F Woolson; Milos N Budisavljevic
Related Documents :
10553816 - Regional capnometry with air-automated tonometry detects circulatory failure earlier th...
9759556 - Osteoporosis in patients with cystic fibrosis.
19848046 - Airway clearance therapy in cystic fibrosis patients.
1679476 - Immunogenetic prediction of pulmonary fibrosis in systemic sclerosis.
3407386 - Subcortical arteriosclerotic encephalopathy: a clinical and radionuclide brain scintisc...
22461186 - Serum levels of selected chemokines in systemic lupus erythematosus patients.
Publication Detail:
Type:  Journal Article     Date:  2007-09-21
Journal Detail:
Title:  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association     Volume:  22     ISSN:  0931-0509     ISO Abbreviation:  Nephrol. Dial. Transplant.     Publication Date:  2007 Nov 
Date Detail:
Created Date:  2007-10-30     Completed Date:  2008-03-10     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8706402     Medline TA:  Nephrol Dial Transplant     Country:  England    
Other Details:
Languages:  eng     Pagination:  3179-85     Citation Subset:  IM    
Affiliation:
Department of Biostatistics, Bioinformatics and Epidemiology, Division of Nephrology, Medical University of South Carolina, 171 Ashley Avenue, Charleston, SC, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Contrast Media / toxicity
Fibrosis / chemically induced
Gadolinium / toxicity*
Humans
Kidney Failure / chemically induced*
Kidney Failure, Chronic / therapy*
Magnetic Resonance Imaging / methods
Peritoneal Dialysis, Continuous Ambulatory*
Retrospective Studies
Skin Diseases / chemically induced*
Chemical
Reg. No./Substance:
0/Contrast Media; 7440-54-2/Gadolinium

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Seasonal variations in serum sodium levels and other biochemical parameters among peritoneal dialysi...
Next Document:  Theoretical calculation of optimal depth in the percutaneous native kidney biopsy to drastically red...